Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LORAZEPAM vs LORMETAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LORAZEPAM vs LORMETAZEPAM: Safety Overview

Metric LORAZEPAM LORMETAZEPAM
Total FAERS Reports 33,404 3,074
Deaths Reported 6,187 384
Death Rate 18.5% 12.5%
Hospitalizations 15,431 1,763
Average Patient Age 49.8 yrs 54.2 yrs
% Female Patients 60.8% 60.0%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. N/A
Route INTRAMUSCULAR N/A
Marketing Status Prescription N/A